Myriad Genetics
MYGN
$18.63
Share price
0.16%
Change (1 day)
-14.81%
Change (1 year)
Myriad Genetics (MYGN) Fails to deliver data
Key failure to deliver metrics for Myriad Genetics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.02 M
- Last 3 months FTD volume: $0.4 M
- Last year FTD volume: $1.25 M
Failures to deliver for Myriad Genetics (MYGN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Myriad Genetics (MYGN) - since 2013
Volume in USD (price x number of shares), data since 2013Myriad Genetics (MYGN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.39 M | -77.2% |
| 2023 | $1.72 M | -31.63% |
| 2022 | $2.51 M | -65.06% |
| 2021 | $7.2 M | 55% |
| 2020 | $4.64 M | -57.42% |
| 2019 | $10.91 M | -16.03% |
| 2018 | $12.99 M | -66.88% |
| 2017 | $39.23 M | 37.96% |
| 2016 | $28.44 M | -83.11% |
| 2015 | $0.16 B | -65.22% |
| 2014 | $0.48 B | 171.86% |
| 2013 | $0.17 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $62.08 M | $0.14 B | 🇺🇸 USA |
 Exact Sciences EXAS | $5.5 M | $33.16 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |
 Biocept
BIOC | $3.88 M | $3.88 M | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $0.1 M | $7.79 M | 🇺🇸 USA |